Free Trial

Lixte Biotechnology (LIXT) Insider Trading & Ownership

$2.28
-0.03 (-1.30%)
(As of 05/29/2024 ET)

Lixte Biotechnology (NASDAQ:LIXT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$28,000.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get LIXT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LIXT Insider Buying and Selling by Quarter

Lixte Biotechnology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/3/2023Der Baan Bastiaan Jeroen VanCEOBuy10,000$2.80$28,000.00  
(Data available from 1/1/2013 forward)

LIXT Insider Trading Activity - Frequently Asked Questions

Who is on Lixte Biotechnology's Insider Roster?

The list of insiders at Lixte Biotechnology includes Der Baan Bastiaan Jeroen Van, Eric Forman, Regina Brown, and Rene Bernards. Learn more on insiders at LIXT.

What percentage of Lixte Biotechnology stock is owned by insiders?

15.50% of Lixte Biotechnology stock is owned by insiders. Learn more on LIXT's insider holdings.

Which Lixte Biotechnology insiders have been buying company stock?

The following insiders have purchased LIXT shares in the last 24 months: Der Baan Bastiaan Jeroen Van ($28,000.00), Eric Forman ($3,431.00), Regina Brown ($2,900.00), and Rene Bernards ($41,575.00).

How much insider buying is happening at Lixte Biotechnology?

Insiders have purchased a total of 18,880 LIXT shares in the last 24 months for a total of $75,906.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:LIXT) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners